November 19, 2024 - Join us for the first seminar in our new series!
“Navigating ER+ HER2- Early Breast Cancer”
The session “What`s new for high-risk early breast cancer patients” will focus on CDK4/6 inhibitors in the adjuvant setting for high-risk breast cancer patients, featuring a real-life case discussion and insights into the potential role of gene expression tests, including prospective validation data in high- risk patients (UNIRAD).
Eurobio Scientific UK is thrilled to announce its new partnership with UTAK, an esteemed American company specialising in Toxicology quality control solutions.
BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Readyâ„¢ PCR assay for detection of Candida auris, a rapidly spreading, hard to treat fungus with a growing presence in hospitals and long-term care facilities.
Vela Diagnostics, a manufacturer of NGS and PCR workflows based in Germany, has partnered with Eurobio Scientific UK; in an exclusive agreement to distribute and represent its products in the UK and Ireland.
In the UK and Ireland, Eurobio Scientific UK will support its existing customers, its equipment and workflow, also delivering 1st line support.
